“…For example, HLA-DRB1 * 13:02 has been shown to confer protection against various illnesses ranging from hepatitis B and C (Singh et al, 2007), influenza (Posteraro et al, 2014), HIV (Pereyra et al, 2010), malaria (Hill et al, 1991), and numerous autoimmune disorders (Bettencourt et al, 2015). Perhaps the most relevant in this case is recent evidence of HLA-protection against structural and functional age-related brain changes (James et al, 2018a,b). Notably, DRB1 * 13:02, has been shown to not only protect against age-related deterioration in neural network functioning, but also to negate the deleterious effects of apoE4 on neural network functioning (James et al, 2018b; Figure 1, top), suggesting a common pathway.…”